EP4004279A1 - Enzymatic treatment of paper pulp - Google Patents
Enzymatic treatment of paper pulpInfo
- Publication number
- EP4004279A1 EP4004279A1 EP20744037.1A EP20744037A EP4004279A1 EP 4004279 A1 EP4004279 A1 EP 4004279A1 EP 20744037 A EP20744037 A EP 20744037A EP 4004279 A1 EP4004279 A1 EP 4004279A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pulp
- xylanase
- seq
- polypeptide
- clade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001131 Pulp (paper) Polymers 0.000 title claims description 76
- 238000011282 treatment Methods 0.000 title claims description 45
- 230000002255 enzymatic effect Effects 0.000 title description 8
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims abstract description 172
- 238000000034 method Methods 0.000 claims description 98
- 102000004190 Enzymes Human genes 0.000 claims description 72
- 108090000790 Enzymes Proteins 0.000 claims description 72
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 66
- 229920001184 polypeptide Polymers 0.000 claims description 65
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 65
- 229940088598 enzyme Drugs 0.000 claims description 64
- 239000000706 filtrate Substances 0.000 claims description 39
- 150000001413 amino acids Chemical class 0.000 claims description 37
- 238000004061 bleaching Methods 0.000 claims description 37
- 230000000694 effects Effects 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 20
- 108010059892 Cellulase Proteins 0.000 claims description 16
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims description 16
- 238000006467 substitution reaction Methods 0.000 claims description 15
- 238000012217 deletion Methods 0.000 claims description 12
- 230000037430 deletion Effects 0.000 claims description 12
- 238000003780 insertion Methods 0.000 claims description 12
- 230000037431 insertion Effects 0.000 claims description 12
- 229940106157 cellulase Drugs 0.000 claims description 10
- 102000004316 Oxidoreductases Human genes 0.000 claims description 9
- 108090000854 Oxidoreductases Proteins 0.000 claims description 9
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 9
- 108010065511 Amylases Proteins 0.000 claims description 8
- 102000013142 Amylases Human genes 0.000 claims description 8
- 239000004155 Chlorine dioxide Substances 0.000 claims description 8
- 108090001060 Lipase Proteins 0.000 claims description 8
- 102000004882 Lipase Human genes 0.000 claims description 8
- 239000004367 Lipase Substances 0.000 claims description 8
- 235000019418 amylase Nutrition 0.000 claims description 8
- 235000019398 chlorine dioxide Nutrition 0.000 claims description 8
- 235000019421 lipase Nutrition 0.000 claims description 8
- 238000006116 polymerization reaction Methods 0.000 claims description 8
- 101710154526 Lytic chitin monooxygenase Proteins 0.000 claims description 7
- 230000008901 benefit Effects 0.000 claims description 7
- 108010005400 cutinase Proteins 0.000 claims description 7
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 6
- 108090000371 Esterases Proteins 0.000 claims description 6
- 108010055297 Sterol Esterase Proteins 0.000 claims description 6
- 102000000019 Sterol Esterase Human genes 0.000 claims description 6
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 6
- 239000004382 Amylase Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 4
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 4
- 238000011161 development Methods 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 230000008092 positive effect Effects 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 12
- 238000004806 packaging method and process Methods 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 41
- 229940024606 amino acid Drugs 0.000 description 36
- 230000008569 process Effects 0.000 description 33
- 239000002655 kraft paper Substances 0.000 description 32
- 239000000123 paper Substances 0.000 description 22
- 229920001221 xylan Polymers 0.000 description 16
- 150000004823 xylans Chemical class 0.000 description 16
- 125000003275 alpha amino acid group Chemical group 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 11
- -1 GP) Polymers 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 150000008163 sugars Chemical class 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000011121 hardwood Substances 0.000 description 9
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 8
- 238000010411 cooking Methods 0.000 description 8
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 125000003172 aldehyde group Chemical group 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 108010029541 Laccase Proteins 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229960002163 hydrogen peroxide Drugs 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 241000600050 Dyella Species 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 229920005610 lignin Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000004537 pulping Methods 0.000 description 4
- 239000011122 softwood Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 3
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 3
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 3
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 3
- 108700020962 Peroxidase Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229940025131 amylases Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 239000012978 lignocellulosic material Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000010893 paper waste Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000004076 pulp bleaching Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- LTMQZVLXCLQPCT-UHFFFAOYSA-N 1,1,6-trimethyltetralin Chemical compound C1CCC(C)(C)C=2C1=CC(C)=CC=2 LTMQZVLXCLQPCT-UHFFFAOYSA-N 0.000 description 2
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 2
- ZMZGIVVRBMFZSG-UHFFFAOYSA-N 4-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=C(O)C=C1 ZMZGIVVRBMFZSG-UHFFFAOYSA-N 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 2
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 2
- 125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 2
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 108010089807 chitosanase Proteins 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000002761 deinking Substances 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 229940015043 glyoxal Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 238000013031 physical testing Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
- CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
- OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 1
- CDUUKBXTEOFITR-BYPYZUCNSA-N 2-methyl-L-serine Chemical compound OC[C@@]([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-BYPYZUCNSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 244000283070 Abies balsamea Species 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 241001157812 Alternaria brassicicola Species 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 101500002332 Aplysia californica Proline-rich mature peptide Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000723418 Carya Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000221779 Fusarium sambucinum Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 240000000797 Hibiscus cannabinus Species 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 125000002435 L-phenylalanyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
- DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
- KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001335021 Lentinus similis Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JMEWFDUAFKVAAT-WDSKDSINSA-N Met-Asn Chemical compound CSCC[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC(N)=O JMEWFDUAFKVAAT-WDSKDSINSA-N 0.000 description 1
- PNDCUTDWYVKBHX-IHRRRGAJSA-N Met-Asp-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PNDCUTDWYVKBHX-IHRRRGAJSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000203622 Nocardiopsis Species 0.000 description 1
- 241000203619 Nocardiopsis dassonvillei Species 0.000 description 1
- 241001221335 Nocardiopsis sp. Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 101710147372 Reducing end xylose-releasing exo-oligoxylanase Proteins 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 241000228182 Thermoascus aurantiacus Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- HYLNRGXEQACDKG-NYVOZVTQSA-N Trp-Asn-Trp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HYLNRGXEQACDKG-NYVOZVTQSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- CDUUKBXTEOFITR-UHFFFAOYSA-N alpha-methylserine Natural products OCC([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- KTYVHLCLTPLSGC-UHFFFAOYSA-N amino propanoate Chemical class CCC(=O)ON KTYVHLCLTPLSGC-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001451 bismuth ion Inorganic materials 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910001902 chlorine oxide Inorganic materials 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000002003 electron diffraction Methods 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- GCHPUFAZSONQIV-UHFFFAOYSA-N isovaline Chemical compound CCC(C)(N)C(O)=O GCHPUFAZSONQIV-UHFFFAOYSA-N 0.000 description 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
- 108010076363 licheninase Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 239000001062 red colorant Substances 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21C5/00—Other processes for obtaining cellulose, e.g. cooking cotton linters ; Processes characterised by the choice of cellulose-containing starting materials
- D21C5/005—Treatment of cellulose-containing material with microorganisms or enzymes
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21C9/00—After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
- D21C9/10—Bleaching ; Apparatus therefor
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
- D21C9/00—After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
- D21C9/10—Bleaching ; Apparatus therefor
- D21C9/12—Bleaching ; Apparatus therefor with halogens or halogen-containing compounds
- D21C9/14—Bleaching ; Apparatus therefor with halogens or halogen-containing compounds with ClO2 or chlorites
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/005—Microorganisms or enzymes
Definitions
- the present invention relates to treatment of paper pulp with a GH8 xylanase.
- enzymes in the manufacture of paper materials.
- examples of enzymes used for this purpose are proteases, lipases, xylanases, amylases, cellulases, as well as various oxidizing enzymes such as laccases and peroxidases.
- the present invention provides a method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase (X-stage).
- X-stage GH8 xylanase
- the invention relates to a paper pulp prepared by the method of the present invention.
- the invention in another aspect relates to a pulp composition, comprising a paper pulp and a GH8 xylanase.
- An additional aspect of the invention relates to use of a GH8 xylanase for treating a paper pulp.
- lignocellulosic materials e.g. paper pulp and the resulting paper material
- lignocellulosic materials can be modified efficiently with a more controlled (less severe) hydrolysis of xylan by contacting the lignocellulosic material with a GH8 xylanase.
- paper material refers to products, which can be made out of cellulosic pulp, such as printing and writing paper, tissue and towel, newsprint, carton board, containerboard and packaging papers.
- pulp or“paper pulp” means any pulp which can be used for the production of a “paper material”.
- the pulp can be supplied as a virgin pulp, or can be derived from a recycled source.
- the pulp may be a wood pulp, a non-wood pulp or a pulp made from wastepaper.
- a wood pulp may be made from softwood such as pine, redwood, fir, spruce, cedar and hemlock or from hardwood such as maple, alder, birch, hickory, beech, aspen, acacia and eucalyptus.
- a non-wood pulp may be made, e.g., from flax, hemp, wheat straw, bagasse, bamboo, cotton or kenaf.
- a wastepaper pulp may be made by re-pulping wastepaper such as newspaper, mixed office waste, computer print-out, white ledger, magazines, milk cartons, paper cups, packaging materials, etc.
- the pulp to be treated comprises both hardwood pulp and softwood pulp.
- the wood pulp to be treated may be mechanical pulp (such as ground wood pulp, GP), chemical pulp (such as kraft pulp or sulfite pulp), semi-chemical pulp (SCP), thermo-mechanical pulp (TMP), chemi-thermo-mechanical pulp (CTMP), or bleached chemi-thermo-mechanical pulp (BCTMP).
- mechanical pulp such as ground wood pulp, GP
- chemical pulp such as kraft pulp or sulfite pulp
- SCP semi-chemical pulp
- TMP thermo-mechanical pulp
- CMP chemi-thermo-mechanical pulp
- BCTMP bleached chemi-thermo-mechanical pulp
- TMP thermo-mechanical pulp
- GW groundwood pulp
- PGW pressurized groundwood pulp
- RMP refiner mechanical pulp
- PRMP pressurized refiner mechanical pulp
- CTMP chemi-thermo-mechanical pulp.
- Chemical pulp is manufactured by either an alkaline cooking (e.g. Kraft or soda cooking) or by an acidic-neutral cooking (e.g. sulfite cooking) whereby most of the lignin is removed.
- alkaline cooking e.g. Kraft or soda cooking
- acidic-neutral cooking e.g. sulfite cooking
- sodium sulphide or sodium hydroxide are used as principal cooking chemicals.
- the sulfite cooking process can cover almost the whole pH range, for instance the pH can be below 1 for sulfur dioxide solutions in water, to above 13 for sodium sulfite solutions with the addition of free sodium hydroxide, but it is more often used in the acidic- neutral range.
- the kraft pulp to be treated may be a bleached kraft pulp, which may consist of softwood bleached kraft (SWBK, also called NBKP (Nadel Holz Bleached Kraft Pulp)), hardwood bleached kraft (HWBK, also called LBKP (Laub Holz Bleached Kraft Pulp)) or a mixture of these.
- SWBK softwood bleached kraft
- HWBK hardwood bleached kraft
- LBKP Lab Holz Bleached Kraft Pulp
- the pulp to be used in the process of the invention is a suspension of mechanical or chemical pulp or a combination thereof.
- the pulp to be used in the process of the invention may comprise 0%, 10-20%, 20-30%, 30-40%, 40-50%, 50-60%, 60-70%, 70-80%, 80- 90%, or 90-100% of chemical pulp.
- a chemical pulp forms part of the pulp being used for manufacturing the paper material.
- the expression “forms part of” means that in the pulp to be used in the process of the invention, the percentage of chemical pulp lies within the range of 1 -99%.
- the percentage of chemical pulp lies within the range of 2-98%, 3-97%, 4-96%, 5-95%, 6-94%, 7-93%, 8-92%, 9- 91 %, 10-90%, 15-85%, 20-80%, 25-75%, 30-70%, 40-60%, or 45-55%.
- the chemical pulp is a kraft pulp, a sulfite pulp, a semi-chemical pulp (SCP), a thermo-mechanical pulp (TMP), a chemi-thermo-mechanical pulp (CTMP), a bleached chemi-thermo-mechanical pulp (BCTMP).
- the kraft pulp is bleached kraft pulp, for example softwood bleached kraft (SWBK, also called NBKP (Nadel Holz Bleached Kraft Pulp)), hardwood bleached kraft (HWBK, also called LBKP (Laub Holz Bleached Kraft Pulp and)) or a mixture thereof.
- the pulp to be used in the process of the invention may be a never dried pulp or a dried pulp.
- Glycoside hydrolases E.C. 3.2.1. are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a noncarbohydrate moiety.
- a classification system for glycoside hydrolases, based on sequence similarity, has led to the definition of >100 different families. This classification is available on the CAZy (http://www.cazy.org/GH1.html) web site and also discussed at CAZypedia, an online encyclopedia of carbohydrate active enzymes.
- Glycoside hydrolase family 8 in CAZY, GH8 comprises inverting enzymes with several known activities, incl. chitosanase (EC 3.2.1.132); cellulase (EC 3.2.1.4); licheninase (EC 3.2.1.73); endo-1 ,4-p-xylanase (EC 3.2.1.8); reducing-end-xylose releasing exo-oligoxylanase (EC 3.2.1.156).
- polypeptides in GH8 can be separated into multiple distinct sub-clusters, or clades, where we denoted the clades listed below. Distinct motifs for each clade are described in detail below
- GH8 xylanases comprise several well-conserved motifs, one example is the motif “[TS]D[PA]SY” or“(Thr/Ser) Asp (Pro/Ala) Ser Tyr” (SEQ ID NO: 15) situated in positions 203- 207 of the xylanase amino acid sequence shown in SEQ ID NO: 2 and 3, in positions 193-197 of SEQ ID NO: 6 , and in positions 202-206 of SEQ ID NO: 7 and 8.
- the polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“SMDY”.
- a characteristic motif for this subgroup is the motif “MN[FYVILM][GS]MDY” or“Met Asn (Phe/Tyr/Val/lle/Leu/Met) (Gly/Ser) Met Asp Tyr” (SEQ ID NO: 16).
- the polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“ALWNW”.
- a characteristic motif for this subgroup is the motif “A[IL]WNW” or“Ala (lle/Leu) Trp Asn Trp” (SEQ ID NO: 17) corresponding to positions 100 to 104 of the xylanase amino acid sequence shown in SEQ ID NO: 9 and 10, and to positions 101 to 105 in SEQ ID NO: 4 and 5.
- the polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“WFAAAL”.
- a characteristic motif for this subgroup is the motif “W[IF]AAAL” or“Trp (lle/Phe) Ala Ala Ala Leu” (SEQ ID NO: 18) corresponding to positions 134 to 139 of the xylanase amino acid sequence shown in SEQ ID NO: 2 and 3, and to positions. 133 to 138 in SEQ ID NO: 7 and 8.
- the GH8 xylanase comprises an amino acid sequence having a degree of sequence identity to the mature polypeptide of GH8 xylanase of any of SEQ ID NO’s: 1-10 of at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% or 100% (hereinafter“homologous polypeptides”).
- the mature polypeptide comprises or consists of amino acids 29 to 433 of SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8 or SEQ ID NO: 10.
- the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et ai, 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later.
- the parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
- the output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
- the homologous polypeptides comprise amino acid sequences that differ by ten amino acids, preferably by nine amino acids, eight amino acids, seven amino acids, six amino acids, five amino acids, more preferably by four amino acids, even more preferably by three amino acids, most preferably by two amino acids, and even most preferably by one amino acid from the mature polypeptide of any of SEQ ID NO’s: 1 -10.
- GH8 xylanase comprises the mature polypeptide of any of SEQ ID NO’s: 1 -10 or an allelic variant thereof; or a fragment thereof having xylanase activity.
- the GH8 xylanase comprises the amino acid sequence of any of SEQ ID NO’s: 1 -10 or the mature polypeptide thereof. In another preferred aspect, the GH8 xylanase comprises the mature polypeptide of any of SEQ ID NO’s: 1-10. In another preferred aspect, the GH8 xylanase consists of the amino acid sequence of any of SEQ ID NO’s: 1-10. In another preferred aspect, the GH8 xylanase consists of the mature polypeptide of any of SEQ ID NO’s: 1-10.
- the GH8 xylanase is selected from the group consisting of:
- the GH8 xylanase is a polypeptide having GH8 xylanase activity.
- the GH8 xylanase comprises artificial variants comprising a substitution, deletion, and/or insertion of one or more (or several) amino acids of the mature polypeptide of any of SEQ ID NO’s: 1 -10, or a homologous sequence thereof.
- amino acid changes are of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of one to about 30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to about 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a polyhistidine tract, an antigenic epitope or a binding domain.
- conservative substitutions are within the group of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine).
- Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, In, The Proteins, Academic Press, New York.
- the most commonly occurring exchanges are Ala/Ser, Val/lle, Asp/Glu, Thr/Ser, Ala/Gly, Ala/Thr, Ser/Asn, Ala/Val, Ser/Gly, Tyr/Phe, Ala/Pro, Lys/Arg, Asp/Asn, Leu/lle, Leu/Val, Ala/Glu, and Asp/Gly.
- non-standard amino acids such as 4- hydroxyproline, 6-A/-methyl lysine, 2-aminoisobutyric acid, isovaline, and alpha-methyl serine
- a limited number of nonconservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues.
- “Unnatural amino acids” have been modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids.
- Unnatural amino acids can be chemically synthesized, and preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
- amino acid changes are of such a nature that the physico-chemical properties of the GH8 xylanases are altered.
- amino acid changes may improve the thermal stability of the GH8 xylanase, alter the substrate specificity, change the pH optimum, and the like.
- Essential amino acids in the parent GH8 xylanase can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e. , xylanase activity) to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271 : 4699-4708.
- the active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al. , 1992, Science 255: 306-312; Smith et al., 1992, J. Mol. Biol. 224: 899-904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64.
- the identities of essential amino acids can also be inferred from analysis of identities with GH8 xylanases that are related to a GH8 xylanase according to the invention.
- Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625.
- Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochem. 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204), and region-directed mutagenesis (Derbyshire et al. , 1986, Gene 46: 145; Ner et al., 1988, DA/A 7: 127).
- Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized GH8 xylanases expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896).
- Mutagenized DNA molecules that encode active GH8 xylanases can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide GH8 xylanase of interest, and can be applied to GH8 xylanases of unknown structure.
- the total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of any of SEQ ID NO’s: 1-10 is 30, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1.
- Pulp bleaching is defined as a process aimed at removal of colour in cellulosic pulps derived from residual lignin or other colored impurities. Native wood is only slightly colored, whereas residual lignin of a chemical pulp after cooking is highly colored. Traditional concepts for bleaching of pulp include chlorine and oxygen based oxidants which selectively remove chromophore structures present in the pulp. Examples of bleaching are bleaching stages with chlorine (C-stage), chlorine dioxide (D-stage), hydrogen peroxide (P-stage), ozone (Z-stage) and oxygen (O-stage) as well as alkaline extraction stages (E-stage) that can be reinforced by small amount of oxygen and/or hydrogen peroxide.
- the progress in bleaching is followed by measuring the brightness, which is defined as the reflectance of visible blue light from a pad of pulp sheets using a defined spectral band of light having an effective wavelength of 457 nm.
- the ISO standard methods are ISO 2469 or ISO 2470.
- Bleaching to full brightness requires multi-stage application of bleaching chemicals. The first stages in a bleaching sequence are often conceived as delignification, where the majority of residual lignin is removed. The last stages are often referred to brightening stages, in which the chromophores in the pulps are eliminated to attain a high brightness level.
- the ISO brightness of the pulp is determined according to ISO 2470 using pulp handsheets prepared according to ISO 3688.
- the process of the invention is particularly applicable to the modification of lignocellulosic materials, for example, in improving the bleaching of a pulp and/or quality of the final pulp in a process for making paper material.
- the process according to the invention can be carried out at any pulp and paper production stage.
- the enzyme can be added to any holding tank, e.g. to a pulp storing container (storage chest), storage tower, mixing chest or metering chest.
- the enzyme treatment can be performed before the bleaching of pulp, in connection with the pulp bleaching process or after the bleaching.
- the enzyme preparation may be added together with bleaching chemicals such as chlorine or chlorine dioxide. Applying oxygen gas, hydrogen peroxide or ozone or combinations thereof may also carry out the bleaching of pulp.
- the enzyme preparation may also be added together with these substances. Preferably the enzyme preparation is added before or after such bleaching steps.
- the enzyme can also be added to the circulated process water (white water) originating from bleaching and process water (brown water) originating from the mechanical or chemimechanical pulping process. In a particular embodiment of a kraft pulping process, the enzyme is added during the brown-stock washing.
- the term“process water” comprises inter alia 1) water added as a raw material to the paper manufacturing process; 2) intermediate water products resulting from any step of the process for manufacturing the paper material; as well as 3) waste water as an output or by-product of the process.
- the process water is, has been, is being, or is intended for being circulated (re-circulated), i.e., re-used in another step of the process.
- the term “water” in turn means any aqueous medium, solution, suspension, e.g. ordinary tap water, and tap water in admixture with various additives and adjuvants commonly used in paper manufacturing processes.
- the process water has a low content of solid (dry) matter, e.g. below 20%, 18%, 16%, 14%, 12%, 10%, 8%, 7%, 6%, 5%, 4%, 3%, 20% or below 1 % dry matter.
- the process of the invention may be carried out at conventional conditions in the paper and pulp processing.
- the process conditions will be a function of the enzyme(s) applied, the reaction time and the conditions given.
- the enzyme of the invention should be added in an effective amount.
- effective amount is meant the amount sufficient to achieve the desired and expected effect in pulp modification, such as increasing the amount of aldehyde groups in the pulp or removing colored compounds and contaminants leading to a desired bleaching and/or deinking effect, and/or strengthening effect etc.
- the dosage of the GH8 xylanase and additional enzymes, if any, is from about 0.1 mg enzyme protein to about 100,000 mg enzyme protein (of each enzyme) per ton of paper pulp.
- the amount of the GH8 xylanase and additional enzymes is in the range of 0.00001 -20; or 0.0001-20 mg of enzyme (calculated as pure enzyme protein) per gram (dry weight) of pulp material, such as 0.0001 -10 mg/g, 0.0001-1 mg/g, 0.001 -1 mg/g, 0.001-0.1 , or 0.01 -0.1 mg of enzyme per gram of pulp material. Again, these amounts refer to the amount of each enzyme.
- the enzymatic treatment can be done at conventional pulp consistency, e.g. 0.5-15% dry substance.
- the consistency is within the range of 0.5-45%; 0.5-40%; 0.5-35%; 0.5-30%; 0.5-25%; 0.5-20%; 0.5-15%; 0.5-10%; 0.5-8%; 0.5-6%; or 0.5-5% dry substance.
- the enzymatic treatment may be carried out at a temperature of from about 10°C to about 100°C. Further examples of temperature ranges (all “from about” and “to about”) are the following: 20-120°C, 30-120°C, 35-120°C, 37-120°C, 40-120°C, 50-120°C, 60-120°C, 70-120°C, 10-100°C, 10-90°C, 10-80°C, 10-70°C, 10-60°C, and 30-60°C, as well as any combination of the upper and lower values here indicated.
- a typical temperature is from about 20 to 90°C, or 20 to 95°C, preferably from about 40 to 70°C.
- the enzymatic treatment is carried out at atmospheric pressure. But when the temperature exceeds 100°C, the treatment is carried out at a pressure of 1-2 bar (up to 1 bar above atmospheric pressure).
- the enzymatic treatment is carried out at a pH of from about 2 to about 12, preferably at a pH from about 4 to about 9, more preferably at a pH from about 5 to about 8, and most preferably at a pH from about 5.5 to about 7.
- a suitable duration of the enzymatic treatment may be in the range from a few seconds to several hours, e.g. from about 30 seconds to about 48 hours, or from about 1 minute to about 24 hours, or from about 1 minute to about 18 hours, or from about 1 minute to about 12 hours, or from about 1 minute to 5 hours, or from about 1 minute to about 2 hours, or from about 1 minute to about 1 hour, or from about 1 minute to about 30 minutes.
- a typical reaction time is from about 10 minutes to 3 hours, 10 minutes to 10 hours, preferably 15 minutes to 1 hour, or 15 minutes to 2 hours.
- Surfactants and/or dispersants are often present in, and/or added to a pulp.
- the process and use of the present invention may be carried out in the presence of an anionic, non-ionic, cationic and/or zwitterionic surfactant and/or dispersant conventionally used in a pulp.
- anionic surfactants are carboxylates, sulfates, sulphonates or phosphates of alkyl, substituted alkyl or aryl.
- non-ionic surfactants are polyoxyethylene compounds, such as alcohol ethoxylates, propoxylates or mixed ethoxy-/propoxylates, poly-glycerols and other polyols, as well as certain block-copolymers.
- cationic surfactants are water-soluble cationic polymers, such as quartenary ammonium sulfates and certain amines, e.g. epichlorohydrin/dimethylamine polymers (EPI- DMA) and cross-linked solutions thereof, polydiallyl dimethyl ammonium chloride (DADMAC), DADMAC/Acrylamide co-polymers, and ionene polymers, such as those disclosed in US patents nos.
- zwitterionic or amphoteric surfactants are betains, glycinates, amino propionates, imino propionates and various imidazolin-derivatives. Also the polymers disclosed in US patent no. 5,256,252 may be used.
- surfactants such as the above, including any combination thereof may be used in a paper making process together with a GH8 xylanase, as defined herein, and included in a composition together with such enzyme.
- the amount of each surfactant in such composition may amount to from about 1 to about 1000 ppm of the composition. In particular embodiments the amount of each surfactant is from about 10 to about 1000 ppm, or from about 10 to about 500 ppm, or from about 50 to about 500 ppm.
- each of the above ranges refers to the total amount of surfactants.
- the GH8 xylanase is used in an amount of 0.005-50 ppm (mg/L), or 0.01 -40, 0.02-30, 0.03-25, 0.04-20, 0.05-15, 0.05-10, 0.05-5, 0.05-1 , 0.05-0.8, 0.05-0.6, or 0.1-0.5 ppm.
- the amount of enzyme refers to mg of a well-defined enzyme preparation.
- the GH8 xylanase may be applied alone or together with an additional enzyme.
- an additional enzyme means at least one additional enzyme, e.g. one, two, three, four, five, six, seven, eight, nine, ten or even more additional enzymes.
- the term “applied together with” means that the additional enzyme may be applied in the same, or in another step of the process of the invention.
- the other process step may be upstream or downstream in the paper manufacturing process, as compared to the step in which the pulp is treated with a GH8 xylanase.
- the additional enzyme is an enzyme which has protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, the lytic polysaccharide monooxygenase and/or cholesterol esterase activity.
- oxidoreductase enzymes are enzymes with laccase, and/or peroxidase activity.
- the additional enzyme is cellulase.
- a step of a process means at least one step, and it could be one, two, three, four, five or even more process steps.
- the GH8 xylanase may be applied in at least one process step, and the additional enzyme(s) may also be applied in at least one process step, which may be the same or a different process step as compared to the step where the GH8 xylanase is used.
- the term“enzyme preparation” means a product containing at least one GH8 xylanase.
- the enzyme preparation may also comprise enzymes having other enzyme activities.
- such a preparation preferably contains at least one adjuvant.
- adjuvants which are used in enzyme preparations for the paper and pulp industry are buffers, polymers, surfactants and stabilizing agents.
- Any enzyme having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity can be used as additional enzymes in the use and process of the invention. Below some non-limiting examples are listed of such additional enzymes. The enzymes written in capitals are commercial enzymes available from Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark. The activity of any of those additional enzymes can be analyzed using any method known in the art for the enzyme in question, including the methods mentioned in the references cited.
- cutinases are those derived from Humicola insolens (US 5,827,719); from a strain of Fusarium, e.g. F. roseum culmorum, or particularly F. solani pisi (WO 90/09446; WO 94/14964, WO 94/03578).
- the cutinase may also be derived from a strain of Rhizoctonia, e.g. R. solani, or a strain of Alternaria, e.g. A. brassicicola (WO 94/03578), or variants thereof such as those described in WO 00/34450, or WO 01/92502.
- proteases examples include the ALCALASE, ESPERASE, SAVINASE, NEUTRASE and DURAZYM proteases.
- Other proteases are derived from Nocardiopsis, Aspergillus, Rhizopus, Bacillus alcalophilus, B. cereus, B. natto, B. vulgatus, B. mycoide, and subtilisins from Bacillus, especially proteases from the species Nocardiopsis sp. and Nocardiopsis dassonvillei such as those disclosed in WO 88/03947, and mutants thereof, e.g. those disclosed in WO 91/00345 and EP 415296.
- amylases are the BAN, AQUAZYM, TERMAMYL, and AQUAZYM Ultra amylases.
- An example of a lipase is the RESINASE A2X lipase.
- An example of a xylanase is the PULPZYME HC hemicellulase.
- Examples of endoglucanases are the NOVOZYM 613, 342, and 476 enzyme products.
- mannanases are the Trichoderma reesei endo-beta-mannanases described in Stahlbrand et al, J. Biotechnol. 29 (1993), 229-242.
- steryl esterases peroxidases examples include laccases, and cholesterol esterases.
- oxidoreductases are the peroxidases and laccases disclosed in EP 730641 ; WO 01/98469; EP 719337; EP 765394; EP 767836; EP 7631 15; and EP 788547.
- acceptors e.g. oxygen or hydrogenperoxide
- enhancers e.g. oxygen or hydrogenperoxide
- mediators and/or activators such compounds should be considered to be included.
- enhancers and mediators are disclosed in EP 705327; WO 98/56899; EP 677102; EP 781328; and EP 707637. If desired a distinction could be made by defining an oxidoreductase enzyme system (e.g. a laccase, or a peroxidase enzyme system) as the combination of the enzyme in question and its acceptor, and optionally also an enhancer and/or mediator for the enzyme in question.
- an oxidoreductase enzyme system e.g. a laccase, or a peroxidase enzyme system
- lytic polysaccharide monooxygenase examples include those derived from Thielavia terrestres (mature polypeptide of SEQ ID NO: 8 of WO 2010/080532A); from Lentinus similis (mature polypeptide of SEQ ID NO: 6 of W02014/066141A); from Thermoascus aurantiacus (mature polypeptide of SEQ ID NO: 2 of W02005/074656A).
- compositions are compositions, methods and uses
- the invention provides a method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase.
- the GH8 xylanase is an endo-beta-1 ,4-xylanase.
- the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade. In an embodiment, the GH8 xylanase is selected from the group consisting of:
- the amino acid sequence of the GH8 xylanase may have at least 60% sequence identity, preferably at least 65% sequence identity, more preferably at least 70% sequence identity, more preferably at least 75% sequence identity, more preferably at least 80% sequence identity, more preferably at least 85% sequence identity, more preferably at least 90% sequence identity, more preferably at least 95%, 96%, 97%, 98%, 99%, and most preferably 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10.
- the number of amino acid substitutions, deletions and/or insertions introduced into the mature polypeptide of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10 is up to 10, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10; or up to 5, e.g. , 1 , 2, 3, 4, or 5.
- the GH8 xylanase is a GH8 xylanase fragment that has GH8 xylanase activity.
- the GH8 xylanase is derived from Bacillus, such as Bacillus sp. KK-1 , or Bacillus Hcheniformis ⁇ , Metagenome from environmental sample; Dyella, such as Dyella sp- 62206.
- the pulp is wood pulp. In an embodiment, the pulp is non-wood cellulosic pulp.
- the pulp is a chemical pulp, such as kraft pulp.
- the method of the invention further comprises a step of bleaching, and/or alkaline extraction (E stage).
- the method of the invention comprises a sequence of treatments selected from the group consisting of:
- X is a GH8 xylanase treatment stage
- B is a bleaching stage, preferably a chlorine dioxide bleaching stage, and
- XB is a GH8 xylanase treatment together with a bleaching stage.
- the method of the invention further comprises contacting the pulp with one or more additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
- additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
- an average degree of polymerization of the xylosaccharides in a filtrate from the pulp obtained from the method of the present invention is 3.5-8, preferably 4-7.
- the method of the invention produces a more controlled (less severe) hydrolysis of xylan and thereby having a more xylan retaining modification of pulp xylan as compared to the other xylanase families typically used in lignocellulosic processing (particularly GH10 and GH1 1 families) while still improving pulp properties, such as brightness and strength. This has a significant importance as xylan loss needs to be minimized in paper pulp production.
- the method of the present invention results in an improved benefit/harm balance with regard to a positive effect on strength and/or brightness development and/or dewatering of the pulp while minimizing a negative effect on pulp yield, and/or COD of the resulting filtrate/effluent, compared with a method with the GH8 xylanase treatment replaced by a GH10 xylanase treatment or GH1 1 xylanase treatment.
- the method of the invention further comprises a final step of preparing a paper material from the pulp.
- the present invention relates to a paper pulp prepared by the method of the present invention.
- the invention provides a pulp composition, comprising a paper pulp and a GH8 xylanase.
- the GH8 xylanase is selected from the group consisting of:
- the pulp is wood pulp. In an embodiment, the pulp is a chemical pulp, such as kraft pulp.
- the invention provides a paper material, which is made from the pulp composition of the invention, or which is made from a paper pulp subjected to the method of the invention.
- the invention also provides for use of the methods and compositions above for treating a paper pulp.
- the GH8 xylanase boosts bleaching and/or increases brightness and/or increases strength and/or improves dewatering of a paper pulp.
- a method for treating a paper pulp comprising contacting the paper pulp with a GH8 xylanase (X-stage).
- GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade.
- GH8 xylanase is derived from Bacillus, such as Bacillus sp. KK-1 , or Bacillus licheniformis; Metagenome from environmental sample; Dyella, such as Dyella sp-62206.
- X is a GH8 xylanase treatment stage
- B is a bleaching stage, preferably a chlorine dioxide bleaching stage, and
- XB is a GH8 xylanase treatment together with a bleaching stage.
- any of items 1 to 9 which further comprises contacting the pulp with one or more additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
- additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
- a pulp composition comprising a paper pulp and a GH8 xylanase.
- GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: the SMDY clade, ALWNW clade, and WFAAAL clade.
- pulp handsheets were prepared according to ISO 3688 and using a Color Touch PC spectrophotometer from Technidyne.
- pulp handsheets were prepared according to TAPPI standard T205.
- the handsheets were conditioned for at least 24 hours in a controlled humidity (50.0% ⁇ 2.0% RH) and temperature (23.0 ⁇ 1 0°C) atmosphere before being measured in the same room.
- the physical testing of the handsheets was conducted as described in TAPPI standard T220.
- the tensile test procedure was based on Tappi standard T using the Instron 5564 tester.
- the burst test procedure was based on Tappi standard T 403 using a L&W Burst-O-Matic tester.
- the amount of aldehyde groups in pulps was measured spectrophotometrically (UV-Vis spectrophotometer HP 8453A, model G1103A) according to the procedure described by Obolenskaya et al., “Determination of aldehyde groups in oxidized pulps”, Laboratory Manipulations in Wood and Cellulose Chemistry, Ecologia, Moscow, 21 1-212, 1991 , which is based on the reaction of 2,3,5-triphenyltetrazolium chloride (TTC) with the aldehyde groups leading to the formation of formazan (red colorant).
- TTC 2,3,5-triphenyltetrazolium chloride
- the COD determination in the pulp filtrates was performed using a COD Cell Test from Merck.
- the reaction cells with the diluted filtrate were put in a thermo reactor TR 620 at 148 °C for 2 hours and then allowed to cool down before measurement in the photometer Spectroquant ® NOVA60 within 60 min after the reaction.
- the Absorbance of the pulp filtrates was measured with a UV-Vis spectrophotometer HP 8453A, model G1 103A.
- reducing sugars CHO groups
- a microtiter plate method based on p-Hydroxybenzoic acid hydrazide (PHBAH) was utilized as reducing sugars react with hydrazides of benzoic acids in an alkaline medium to yield the bis- benzoylhydrazones of glyoxal and methylglyoxal, both of which had intense yellow color.
- the rate of reaction was accelerated by the catalytic influence of bismuth ions and the generation of the glyoxal and methylglyoxal derivatives was monitored at 405 nm and was proportional to the amount of reducing sugars concentration as calculated from a standard curve constructed from xylose calibration standards.
- the pulp filtrates were measured as it was for RS and as well after a secondary enzymatic hydrolysis with a beta-xylosidase (200 pl_ of pulp filtrate at buffered pH 3.5 with 0,002 mg EP/mL at 50°C for 60 min) to convert the small xylosaccharides (XOS) present in the filtrate into xylose and thereby increase the response of the reducing sugar assay.
- the ratio of the RS value with beta-xylosidase to the RS value without beta-xylosidase was an indication of the average degree of polymerization of the XOS present in the pulp filtrates.
- Chemicals used as buffers and substrates were commercial products of at least reagent grade.
- Bleached northern mixed hardwood kraft pulp in sheet form (dry lap market paper-grade pulp) was teared by hand and soaked in distilled water overnight and then disintegrated in a pulp disintegrator at 10000 rpm. After disintegration, the pulp was filtered and crumbled before being used in the experiments. Typically, 20 g odp (oven-dry pulp; dry matter basis) was treated with a xylanase at 10% consistency, 45°C and pH 4.5 (acetate buffer) for 4 hours using 10 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp suspension was incubated in sealed polyethylene plastic bags immersed in a temperature controlled water bath. After incubation, the pulp was filtered and the filtrate collected. The pulp was then washed and filtered in three consecutive steps with 1 L of warm tap water. Control experiments were run in parallel under the same conditions except for the use of enzyme.
- EP enzyme protein
- GH8 xylanases produced a more controlled (less severe) hydrolysis of xylan and thereby had a more xylan retaining modification of pulp xylan as compared to the other xylanase families while still improving pulp properties, such as brightness. This had a significant importance as xylan loss needed to be avoided in paper pulp production.
- EXAMPLE 2 Effect of xylanase treatment in the pre-bleachinq of an unbleached pulp on bleach boosting performance
- An unbleached eucalypt kraft pulp was submitted to a sequence of treatments in the following order: xylanase (X-stage), followed by chlorine dioxide bleaching (D-stage) and then an alkaline extraction reinforced with hydrogen peroxide (Ep-stage) with pulp washing in between each stage. Thirty grams of pulp (as oven-dry pulp) were treated at 50°C, pH 6 (phosphate buffer), for 120 min with a dosage of xylanase of 10 mg EP/kg odp.
- the chlorine dioxide treatment was done using 1 .12 % odp CI0 (100% dosage) or 0.95% odp CI0 2 (85% dosage), 70°C, initial pH of 3,0 (adjusted with sulfuric acid) for 60 min.
- the Ep-stage was performed at 75°C, using 1.35 % odp NaOH and 0.20% odp H 2 0 2 for 60 min. All pulp treatments were run at 10% consistency in sealed polyethylene plastic bags immersed in a temperature controlled water bath.
- a bleached never dried eucalypt kraft pulp was treated with GH8 and GH1 1 xylanases as a post-bleaching step.
- 20 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 55°C and pH 6.0 (phosphate buffer) for 2 hours using 1.5, 4.0 and 10 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis).
- EP enzyme protein
- a bleached never dried hardwood kraft pulp was treated with GH8, GH10 and GH1 1 xylanases as a post-bleaching step.
- 10 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 45°C and pH 6.0 (phosphate buffer) for 3 and 20 hours using 2.0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis).
- EP enzyme protein
- the GH8 xylanases show once again a surprisingly higher average degree of polymerization of the released XOS compared to the GH10 and GH1 1 xylanases after a long incubation time of 20h.
- a bleached never dried hardwood kraft pulp was treated with GH8, GH10 and GH1 1 xylanases as a post-bleaching step.
- 5 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 65°C and pH 6.0 (phosphate buffer) for 20 hours using 1 .0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis).
- EP enzyme protein
- EXAMPLE 6 Effect of a xylanase treatment using a bleached eucalypt kraft market paper-grade pulp
- a bleached eucalypt market kraft paper-grade pulp (dried pulp) was treated with GH8, GH10 and GH1 1 xylanases.
- 5 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 65°C and pH 6.0 (phosphate buffer) for 23 hours using 1.0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis).
- EP enzyme protein
- oven-dry pulp oven-dry pulp; dry matter basis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Paper (AREA)
Abstract
The use of a GH8 xylanase in the treating of pulp for preparing paper materials, such as printing and writing paper, tissue and towel, newsprint, carton board, containerboard and packaging papers.
Description
ENZYMATIC TREATMENT OF PAPER PULP
Reference to a Sequence Listing
This application contains a Sequence Listing in computer readable form, which is incorporated herein by reference.
FIELD OF THE INVENTION
The present invention relates to treatment of paper pulp with a GH8 xylanase.
BACKGROUND
It is well-known to use enzymes in the manufacture of paper materials. Examples of enzymes used for this purpose are proteases, lipases, xylanases, amylases, cellulases, as well as various oxidizing enzymes such as laccases and peroxidases.
The effects of these enzymes are wide-spread, e.g., control of various deposits such as pitch, strength-improvement, deinking, drainage improvement, tissue softening, bleaching etc.
SUMMARY OF THE INVENTION
In one aspect, the present invention provides a method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase (X-stage).
In another aspect the invention relates to a paper pulp prepared by the method of the present invention.
In another aspect the invention relates to a pulp composition, comprising a paper pulp and a GH8 xylanase.
An additional aspect of the invention relates to use of a GH8 xylanase for treating a paper pulp.
DETAILED DESCRIPTION
The present inventors surprisingly found that lignocellulosic materials (e.g. paper pulp and the resulting paper material) can be modified efficiently with a more controlled (less severe) hydrolysis of xylan by contacting the lignocellulosic material with a GH8 xylanase.
Paper and Pulp
The term“paper material” refers to products, which can be made out of cellulosic pulp, such as printing and writing paper, tissue and towel, newsprint, carton board, containerboard and packaging papers.
The term“pulp” or“paper pulp” means any pulp which can be used for the production of a “paper material”. For example, the pulp can be supplied as a virgin pulp, or can be derived from a recycled source. The pulp may be a wood pulp, a non-wood pulp or a pulp made from
wastepaper. A wood pulp may be made from softwood such as pine, redwood, fir, spruce, cedar and hemlock or from hardwood such as maple, alder, birch, hickory, beech, aspen, acacia and eucalyptus. A non-wood pulp may be made, e.g., from flax, hemp, wheat straw, bagasse, bamboo, cotton or kenaf. A wastepaper pulp may be made by re-pulping wastepaper such as newspaper, mixed office waste, computer print-out, white ledger, magazines, milk cartons, paper cups, packaging materials, etc.
In a particular embodiment, the pulp to be treated comprises both hardwood pulp and softwood pulp.
The wood pulp to be treated may be mechanical pulp (such as ground wood pulp, GP), chemical pulp (such as kraft pulp or sulfite pulp), semi-chemical pulp (SCP), thermo-mechanical pulp (TMP), chemi-thermo-mechanical pulp (CTMP), or bleached chemi-thermo-mechanical pulp (BCTMP).
Mechanical pulp is manufactured by the grinding and refining methods, wherein the raw material is subjected to periodical pressure impulses. TMP is thermo-mechanical pulp, GW is groundwood pulp, PGW is pressurized groundwood pulp, RMP is refiner mechanical pulp, PRMP is pressurized refiner mechanical pulp and CTMP is chemi-thermo-mechanical pulp.
Chemical pulp is manufactured by either an alkaline cooking (e.g. Kraft or soda cooking) or by an acidic-neutral cooking (e.g. sulfite cooking) whereby most of the lignin is removed. In kraft pulping or sulfate cooking sodium sulphide or sodium hydroxide are used as principal cooking chemicals. The sulfite cooking process can cover almost the whole pH range, for instance the pH can be below 1 for sulfur dioxide solutions in water, to above 13 for sodium sulfite solutions with the addition of free sodium hydroxide, but it is more often used in the acidic- neutral range.
The kraft pulp to be treated may be a bleached kraft pulp, which may consist of softwood bleached kraft (SWBK, also called NBKP (Nadel Holz Bleached Kraft Pulp)), hardwood bleached kraft (HWBK, also called LBKP (Laub Holz Bleached Kraft Pulp)) or a mixture of these.
The pulp to be used in the process of the invention is a suspension of mechanical or chemical pulp or a combination thereof. For example, the pulp to be used in the process of the invention may comprise 0%, 10-20%, 20-30%, 30-40%, 40-50%, 50-60%, 60-70%, 70-80%, 80- 90%, or 90-100% of chemical pulp. In a particular embodiment, a chemical pulp forms part of the pulp being used for manufacturing the paper material. In the present context, the expression “forms part of means that in the pulp to be used in the process of the invention, the percentage of chemical pulp lies within the range of 1 -99%. In particular embodiments, the percentage of chemical pulp lies within the range of 2-98%, 3-97%, 4-96%, 5-95%, 6-94%, 7-93%, 8-92%, 9- 91 %, 10-90%, 15-85%, 20-80%, 25-75%, 30-70%, 40-60%, or 45-55%.
In a particular embodiment of the use and the process of the invention, the chemical pulp is a kraft pulp, a sulfite pulp, a semi-chemical pulp (SCP), a thermo-mechanical pulp (TMP), a
chemi-thermo-mechanical pulp (CTMP), a bleached chemi-thermo-mechanical pulp (BCTMP). In particular embodiments the kraft pulp is bleached kraft pulp, for example softwood bleached kraft (SWBK, also called NBKP (Nadel Holz Bleached Kraft Pulp)), hardwood bleached kraft (HWBK, also called LBKP (Laub Holz Bleached Kraft Pulp and)) or a mixture thereof.
The pulp to be used in the process of the invention may be a never dried pulp or a dried pulp.
GH8 Xylanase
Glycoside hydrolases E.C. 3.2.1. are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a noncarbohydrate moiety. A classification system for glycoside hydrolases, based on sequence similarity, has led to the definition of >100 different families. This classification is available on the CAZy (http://www.cazy.org/GH1.html) web site and also discussed at CAZypedia, an online encyclopedia of carbohydrate active enzymes.
Glycoside hydrolase family 8 in CAZY, GH8, comprises inverting enzymes with several known activities, incl. chitosanase (EC 3.2.1.132); cellulase (EC 3.2.1.4); licheninase (EC 3.2.1.73); endo-1 ,4-p-xylanase (EC 3.2.1.8); reducing-end-xylose releasing exo-oligoxylanase (EC 3.2.1.156).
The polypeptides in GH8 can be separated into multiple distinct sub-clusters, or clades, where we denoted the clades listed below. Distinct motifs for each clade are described in detail below
(a) DPSY clade
(b) SMDY clade
(c) ALWNW clade
(d) WFAAAL clade.
The DPSY clade
GH8 xylanases comprise several well-conserved motifs, one example is the motif “[TS]D[PA]SY” or“(Thr/Ser) Asp (Pro/Ala) Ser Tyr” (SEQ ID NO: 15) situated in positions 203- 207 of the xylanase amino acid sequence shown in SEQ ID NO: 2 and 3, in positions 193-197 of SEQ ID NO: 6 , and in positions 202-206 of SEQ ID NO: 7 and 8.
The SMDY clade
The polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“SMDY”. A characteristic motif for this subgroup is the motif “MN[FYVILM][GS]MDY” or“Met Asn (Phe/Tyr/Val/lle/Leu/Met) (Gly/Ser) Met Asp Tyr” (SEQ ID NO: 16).
The ALWNW clade
The polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“ALWNW”. A characteristic motif for this subgroup is the motif
“A[IL]WNW” or“Ala (lle/Leu) Trp Asn Trp” (SEQ ID NO: 17) corresponding to positions 100 to 104 of the xylanase amino acid sequence shown in SEQ ID NO: 9 and 10, and to positions 101 to 105 in SEQ ID NO: 4 and 5.
The WFAAAL clade
The polypeptides of the DPSY clade can be separated into distinct sub-clusters, and one of the sub-clusters we denote“WFAAAL”. A characteristic motif for this subgroup is the motif “W[IF]AAAL” or“Trp (lle/Phe) Ala Ala Ala Leu” (SEQ ID NO: 18) corresponding to positions 134 to 139 of the xylanase amino acid sequence shown in SEQ ID NO: 2 and 3, and to positions. 133 to 138 in SEQ ID NO: 7 and 8.
Preferably, the GH8 xylanase comprises an amino acid sequence having a degree of sequence identity to the mature polypeptide of GH8 xylanase of any of SEQ ID NO’s: 1-10 of at least 60%, more preferably at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, or at least 99% or 100% (hereinafter“homologous polypeptides”).
Even more preferable, is where the mature polypeptide comprises or consists of amino acids 29 to 433 of SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8 or SEQ ID NO: 10.
For purposes of the present invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et ai, 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later. The parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
(Identical Residues x 100)/(Length of Alignment - Total Number of Gaps in Alignment)
In a preferred aspect, the homologous polypeptides comprise amino acid sequences that differ by ten amino acids, preferably by nine amino acids, eight amino acids, seven amino acids, six amino acids, five amino acids, more preferably by four amino acids, even more preferably by three amino acids, most preferably by two amino acids, and even most preferably by one amino acid from the mature polypeptide of any of SEQ ID NO’s: 1 -10. GH8 xylanase comprises the mature polypeptide of any of SEQ ID NO’s: 1 -10 or an allelic variant thereof; or a fragment thereof having xylanase activity. In a preferred aspect, the GH8 xylanase comprises the amino acid sequence of any of SEQ ID NO’s: 1 -10 or the mature polypeptide thereof. In another preferred aspect, the GH8 xylanase comprises the mature polypeptide of any of SEQ ID NO’s: 1-10. In another preferred aspect, the GH8 xylanase consists of the amino acid sequence of any
of SEQ ID NO’s: 1-10. In another preferred aspect, the GH8 xylanase consists of the mature polypeptide of any of SEQ ID NO’s: 1-10.
In a preferred embodiment, the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
According to the present invention, the GH8 xylanase is a polypeptide having GH8 xylanase activity.
In a preferred embodiment, the GH8 xylanase comprises artificial variants comprising a substitution, deletion, and/or insertion of one or more (or several) amino acids of the mature polypeptide of any of SEQ ID NO’s: 1 -10, or a homologous sequence thereof. Preferably, amino acid changes are of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of one to about 30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to about 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a polyhistidine tract, an antigenic epitope or a binding domain.
Examples of conservative substitutions are within the group of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine). Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, In, The Proteins, Academic Press, New York. The most commonly occurring exchanges are Ala/Ser, Val/lle, Asp/Glu, Thr/Ser, Ala/Gly, Ala/Thr, Ser/Asn, Ala/Val, Ser/Gly, Tyr/Phe, Ala/Pro, Lys/Arg, Asp/Asn, Leu/lle, Leu/Val, Ala/Glu, and Asp/Gly.
In addition to the 20 standard amino acids, non-standard amino acids (such as 4- hydroxyproline, 6-A/-methyl lysine, 2-aminoisobutyric acid, isovaline, and alpha-methyl serine) may be substituted for amino acid residues of a wild-type polypeptide. A limited number of nonconservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues.“Unnatural amino acids” have been
modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids. Unnatural amino acids can be chemically synthesized, and preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
Alternatively, the amino acid changes are of such a nature that the physico-chemical properties of the GH8 xylanases are altered. For example, amino acid changes may improve the thermal stability of the GH8 xylanase, alter the substrate specificity, change the pH optimum, and the like.
Essential amino acids in the parent GH8 xylanase can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e. , xylanase activity) to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271 : 4699-4708. The active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al. , 1992, Science 255: 306-312; Smith et al., 1992, J. Mol. Biol. 224: 899-904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64. The identities of essential amino acids can also be inferred from analysis of identities with GH8 xylanases that are related to a GH8 xylanase according to the invention.
Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochem. 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204), and region-directed mutagenesis (Derbyshire et al. , 1986, Gene 46: 145; Ner et al., 1988, DA/A 7: 127).
Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized GH8 xylanases expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active GH8 xylanases can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide GH8 xylanase of interest, and can be applied to GH8 xylanases of unknown structure.
In an embodiment, the total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of any of SEQ ID NO’s: 1-10 is 30, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1.
Bleaching
Pulp bleaching is defined as a process aimed at removal of colour in cellulosic pulps derived from residual lignin or other colored impurities. Native wood is only slightly colored, whereas residual lignin of a chemical pulp after cooking is highly colored. Traditional concepts for bleaching of pulp include chlorine and oxygen based oxidants which selectively remove chromophore structures present in the pulp. Examples of bleaching are bleaching stages with chlorine (C-stage), chlorine dioxide (D-stage), hydrogen peroxide (P-stage), ozone (Z-stage) and oxygen (O-stage) as well as alkaline extraction stages (E-stage) that can be reinforced by small amount of oxygen and/or hydrogen peroxide. The progress in bleaching is followed by measuring the brightness, which is defined as the reflectance of visible blue light from a pad of pulp sheets using a defined spectral band of light having an effective wavelength of 457 nm. Official ISO standard methods are ISO 2469 or ISO 2470. Bleaching to full brightness (> 88% ISO) requires multi-stage application of bleaching chemicals. The first stages in a bleaching sequence are often conceived as delignification, where the majority of residual lignin is removed. The last stages are often referred to brightening stages, in which the chromophores in the pulps are eliminated to attain a high brightness level.
According to the invention, the ISO brightness of the pulp is determined according to ISO 2470 using pulp handsheets prepared according to ISO 3688.
Process Conditions
The process of the invention is particularly applicable to the modification of lignocellulosic materials, for example, in improving the bleaching of a pulp and/or quality of the final pulp in a process for making paper material.
In the case of paper and pulp processing, the process according to the invention can be carried out at any pulp and paper production stage. The enzyme can be added to any holding tank, e.g. to a pulp storing container (storage chest), storage tower, mixing chest or metering chest. The enzyme treatment can be performed before the bleaching of pulp, in connection with the pulp bleaching process or after the bleaching. When carried out in connection with pulp bleaching the enzyme preparation may be added together with bleaching chemicals such as chlorine or chlorine dioxide. Applying oxygen gas, hydrogen peroxide or ozone or combinations thereof may also carry out the bleaching of pulp. The enzyme preparation may also be added together with these substances. Preferably the enzyme preparation is added before or after such bleaching steps. The enzyme can also be added to the circulated process water (white water) originating from bleaching and process water (brown water) originating from the mechanical or
chemimechanical pulping process. In a particular embodiment of a kraft pulping process, the enzyme is added during the brown-stock washing.
In the present context, the term“process water” comprises inter alia 1) water added as a raw material to the paper manufacturing process; 2) intermediate water products resulting from any step of the process for manufacturing the paper material; as well as 3) waste water as an output or by-product of the process. In a particular embodiment, the process water is, has been, is being, or is intended for being circulated (re-circulated), i.e., re-used in another step of the process. The term “water” in turn means any aqueous medium, solution, suspension, e.g. ordinary tap water, and tap water in admixture with various additives and adjuvants commonly used in paper manufacturing processes. In a particular embodiment the process water has a low content of solid (dry) matter, e.g. below 20%, 18%, 16%, 14%, 12%, 10%, 8%, 7%, 6%, 5%, 4%, 3%, 20% or below 1 % dry matter.
The process of the invention may be carried out at conventional conditions in the paper and pulp processing. The process conditions will be a function of the enzyme(s) applied, the reaction time and the conditions given.
The enzyme of the invention should be added in an effective amount. By the term“effective amount” is meant the amount sufficient to achieve the desired and expected effect in pulp modification, such as increasing the amount of aldehyde groups in the pulp or removing colored compounds and contaminants leading to a desired bleaching and/or deinking effect, and/or strengthening effect etc.
In a particular embodiment, the dosage of the GH8 xylanase and additional enzymes, if any, is from about 0.1 mg enzyme protein to about 100,000 mg enzyme protein (of each enzyme) per ton of paper pulp.
In further particular embodiments, the amount of the GH8 xylanase and additional enzymes, if any, is in the range of 0.00001 -20; or 0.0001-20 mg of enzyme (calculated as pure enzyme protein) per gram (dry weight) of pulp material, such as 0.0001 -10 mg/g, 0.0001-1 mg/g, 0.001 -1 mg/g, 0.001-0.1 , or 0.01 -0.1 mg of enzyme per gram of pulp material. Again, these amounts refer to the amount of each enzyme.
The enzymatic treatment can be done at conventional pulp consistency, e.g. 0.5-15% dry substance. In particular embodiments, the consistency is within the range of 0.5-45%; 0.5-40%; 0.5-35%; 0.5-30%; 0.5-25%; 0.5-20%; 0.5-15%; 0.5-10%; 0.5-8%; 0.5-6%; or 0.5-5% dry substance.
The enzymatic treatment may be carried out at a temperature of from about 10°C to about 100°C. Further examples of temperature ranges (all “from about” and “to about”) are the following: 20-120°C, 30-120°C, 35-120°C, 37-120°C, 40-120°C, 50-120°C, 60-120°C, 70-120°C, 10-100°C, 10-90°C, 10-80°C, 10-70°C, 10-60°C, and 30-60°C, as well as any combination of the upper and lower values here indicated. A typical temperature is from about 20 to 90°C, or 20
to 95°C, preferably from about 40 to 70°C. Usually, the enzymatic treatment is carried out at atmospheric pressure. But when the temperature exceeds 100°C, the treatment is carried out at a pressure of 1-2 bar (up to 1 bar above atmospheric pressure).
The enzymatic treatment is carried out at a pH of from about 2 to about 12, preferably at a pH from about 4 to about 9, more preferably at a pH from about 5 to about 8, and most preferably at a pH from about 5.5 to about 7.
A suitable duration of the enzymatic treatment may be in the range from a few seconds to several hours, e.g. from about 30 seconds to about 48 hours, or from about 1 minute to about 24 hours, or from about 1 minute to about 18 hours, or from about 1 minute to about 12 hours, or from about 1 minute to 5 hours, or from about 1 minute to about 2 hours, or from about 1 minute to about 1 hour, or from about 1 minute to about 30 minutes. A typical reaction time is from about 10 minutes to 3 hours, 10 minutes to 10 hours, preferably 15 minutes to 1 hour, or 15 minutes to 2 hours.
Various additives over and above the GH8 xylanase and additional enzymes, if any, can be used in the process or use of the invention. Surfactants and/or dispersants are often present in, and/or added to a pulp. Thus the process and use of the present invention may be carried out in the presence of an anionic, non-ionic, cationic and/or zwitterionic surfactant and/or dispersant conventionally used in a pulp. Examples of anionic surfactants are carboxylates, sulfates, sulphonates or phosphates of alkyl, substituted alkyl or aryl. Examples of non-ionic surfactants are polyoxyethylene compounds, such as alcohol ethoxylates, propoxylates or mixed ethoxy-/propoxylates, poly-glycerols and other polyols, as well as certain block-copolymers. Examples of cationic surfactants are water-soluble cationic polymers, such as quartenary ammonium sulfates and certain amines, e.g. epichlorohydrin/dimethylamine polymers (EPI- DMA) and cross-linked solutions thereof, polydiallyl dimethyl ammonium chloride (DADMAC), DADMAC/Acrylamide co-polymers, and ionene polymers, such as those disclosed in US patents nos. 5,681 ,862; and 5,575,993. Examples of zwitterionic or amphoteric surfactants are betains, glycinates, amino propionates, imino propionates and various imidazolin-derivatives. Also the polymers disclosed in US patent no. 5,256,252 may be used.
Also according to the invention, surfactants such as the above, including any combination thereof may be used in a paper making process together with a GH8 xylanase, as defined herein, and included in a composition together with such enzyme. The amount of each surfactant in such composition may amount to from about 1 to about 1000 ppm of the composition. In particular embodiments the amount of each surfactant is from about 10 to about 1000 ppm, or from about 10 to about 500 ppm, or from about 50 to about 500 ppm.
In another particular embodiment, each of the above ranges refers to the total amount of surfactants.
In further particular embodiments of the above method, and of the process of the invention, the GH8 xylanase is used in an amount of 0.005-50 ppm (mg/L), or 0.01 -40, 0.02-30, 0.03-25, 0.04-20, 0.05-15, 0.05-10, 0.05-5, 0.05-1 , 0.05-0.8, 0.05-0.6, or 0.1-0.5 ppm. The amount of enzyme refers to mg of a well-defined enzyme preparation.
In the process of the invention, the GH8 xylanase may be applied alone or together with an additional enzyme. The term“an additional enzyme” means at least one additional enzyme, e.g. one, two, three, four, five, six, seven, eight, nine, ten or even more additional enzymes.
The term “applied together with” (or“used together with”) means that the additional enzyme may be applied in the same, or in another step of the process of the invention. The other process step may be upstream or downstream in the paper manufacturing process, as compared to the step in which the pulp is treated with a GH8 xylanase.
In particular embodiments the additional enzyme (see also below) is an enzyme which has protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, the lytic polysaccharide monooxygenase and/or cholesterol esterase activity. Examples of oxidoreductase enzymes are enzymes with laccase, and/or peroxidase activity. In a preferred embodiment, the additional enzyme is cellulase.
The term“a step” of a process means at least one step, and it could be one, two, three, four, five or even more process steps. In other words, the GH8 xylanase may be applied in at least one process step, and the additional enzyme(s) may also be applied in at least one process step, which may be the same or a different process step as compared to the step where the GH8 xylanase is used.
The term“enzyme preparation” means a product containing at least one GH8 xylanase. The enzyme preparation may also comprise enzymes having other enzyme activities. In addition to the enzymatic activity, such a preparation preferably contains at least one adjuvant. Examples of adjuvants, which are used in enzyme preparations for the paper and pulp industry are buffers, polymers, surfactants and stabilizing agents.
Additional enzymes
Any enzyme having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity can be used as additional enzymes in the use and process of the invention. Below some non-limiting examples are listed of such additional enzymes. The enzymes written in capitals are commercial enzymes available from Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark. The activity of any of those additional enzymes can be analyzed using any method known in the art for the enzyme in question, including the methods mentioned in the references cited.
Examples of cutinases are those derived from Humicola insolens (US 5,827,719); from a strain of Fusarium, e.g. F. roseum culmorum, or particularly F. solani pisi (WO 90/09446; WO
94/14964, WO 94/03578). The cutinase may also be derived from a strain of Rhizoctonia, e.g. R. solani, or a strain of Alternaria, e.g. A. brassicicola (WO 94/03578), or variants thereof such as those described in WO 00/34450, or WO 01/92502.
Examples of proteases are the ALCALASE, ESPERASE, SAVINASE, NEUTRASE and DURAZYM proteases. Other proteases are derived from Nocardiopsis, Aspergillus, Rhizopus, Bacillus alcalophilus, B. cereus, B. natto, B. vulgatus, B. mycoide, and subtilisins from Bacillus, especially proteases from the species Nocardiopsis sp. and Nocardiopsis dassonvillei such as those disclosed in WO 88/03947, and mutants thereof, e.g. those disclosed in WO 91/00345 and EP 415296.
Examples of amylases are the BAN, AQUAZYM, TERMAMYL, and AQUAZYM Ultra amylases. An example of a lipase is the RESINASE A2X lipase. An example of a xylanase is the PULPZYME HC hemicellulase. Examples of endoglucanases are the NOVOZYM 613, 342, and 476 enzyme products.
Examples of mannanases are the Trichoderma reesei endo-beta-mannanases described in Stahlbrand et al, J. Biotechnol. 29 (1993), 229-242.
Examples of steryl esterases peroxidases, laccases, and cholesterol esterases are disclosed in the references mentioned in the background art section hereof. Further examples of oxidoreductases are the peroxidases and laccases disclosed in EP 730641 ; WO 01/98469; EP 719337; EP 765394; EP 767836; EP 7631 15; and EP 788547. In the present context, whenever an oxidoreductase enzyme is mentioned that requires or benefits from the presence of acceptors (e.g. oxygen or hydrogenperoxide), enhancers, mediators and/or activators, such compounds should be considered to be included. Examples of enhancers and mediators are disclosed in EP 705327; WO 98/56899; EP 677102; EP 781328; and EP 707637. If desired a distinction could be made by defining an oxidoreductase enzyme system (e.g. a laccase, or a peroxidase enzyme system) as the combination of the enzyme in question and its acceptor, and optionally also an enhancer and/or mediator for the enzyme in question.
Examples of the lytic polysaccharide monooxygenase (LPMO) are those derived from Thielavia terrestres (mature polypeptide of SEQ ID NO: 8 of WO 2010/080532A); from Lentinus similis (mature polypeptide of SEQ ID NO: 6 of W02014/066141A); from Thermoascus aurantiacus (mature polypeptide of SEQ ID NO: 2 of W02005/074656A).
Compositions, methods and uses
In a first aspect, the invention provides a method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase.
In an embodiment, the GH8 xylanase is an endo-beta-1 ,4-xylanase.
In an embodiment, the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade.
In an embodiment, the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
The amino acid sequence of the GH8 xylanase may have at least 60% sequence identity, preferably at least 65% sequence identity, more preferably at least 70% sequence identity, more preferably at least 75% sequence identity, more preferably at least 80% sequence identity, more preferably at least 85% sequence identity, more preferably at least 90% sequence identity, more preferably at least 95%, 96%, 97%, 98%, 99%, and most preferably 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10.
In an embodiment, the number of amino acid substitutions, deletions and/or insertions introduced into the mature polypeptide of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10 is up to 10, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, or 10; or up to 5, e.g. , 1 , 2, 3, 4, or 5.
In an embodiment, the GH8 xylanase is a GH8 xylanase fragment that has GH8 xylanase activity.
In an embodiment, the GH8 xylanase is derived from Bacillus, such as Bacillus sp. KK-1 , or Bacillus Hcheniformis·, Metagenome from environmental sample; Dyella, such as Dyella sp- 62206.
In an embodiment, the pulp is wood pulp. In an embodiment, the pulp is non-wood cellulosic pulp.
In an embodiment, the pulp is a chemical pulp, such as kraft pulp.
In an embodiment, the method of the invention further comprises a step of bleaching, and/or alkaline extraction (E stage).
In an embodiment, the method of the invention comprises a sequence of treatments selected from the group consisting of:
a) X-B;
b) B-X;
c) XB;
wherein,
X is a GH8 xylanase treatment stage,
B is a bleaching stage, preferably a chlorine dioxide bleaching stage, and
XB is a GH8 xylanase treatment together with a bleaching stage.
In an embodiment, the method of the invention further comprises contacting the pulp with one or more additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
In an embodiment, an average degree of polymerization of the xylosaccharides in a filtrate from the pulp obtained from the method of the present invention is 3.5-8, preferably 4-7.
In an embodiment, the method of the invention produces a more controlled (less severe) hydrolysis of xylan and thereby having a more xylan retaining modification of pulp xylan as compared to the other xylanase families typically used in lignocellulosic processing (particularly GH10 and GH1 1 families) while still improving pulp properties, such as brightness and strength. This has a significant importance as xylan loss needs to be minimized in paper pulp production.
In an embodiment, the method of the present invention results in an improved benefit/harm balance with regard to a positive effect on strength and/or brightness development and/or dewatering of the pulp while minimizing a negative effect on pulp yield, and/or COD of the resulting filtrate/effluent, compared with a method with the GH8 xylanase treatment replaced by a GH10 xylanase treatment or GH1 1 xylanase treatment.
In an embodiment, the method of the invention further comprises a final step of preparing a paper material from the pulp.
In a further aspect, the present invention relates to a paper pulp prepared by the method of the present invention.
In a further aspect, the invention provides a pulp composition, comprising a paper pulp and a GH8 xylanase.
In a preferred embodiment, the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to the mature polypeptide of a GH8 xylanase selected from the group of GH8 xylanases shown in any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide is at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% identical to the mature polypeptide of a GH8 xylanase shown in any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanse activity.
In an embodiment, the pulp is wood pulp.
In an embodiment, the pulp is a chemical pulp, such as kraft pulp.
In a further aspect, the invention provides a paper material, which is made from the pulp composition of the invention, or which is made from a paper pulp subjected to the method of the invention.
The invention also provides for use of the methods and compositions above for treating a paper pulp.
In an embodiment, the GH8 xylanase boosts bleaching and/or increases brightness and/or increases strength and/or improves dewatering of a paper pulp.
Various references are cited herein, the disclosures of which are incorporated by reference in their entireties.
One specific embodiment of the present invention is described in the set of items herein below.
Items:
1. A method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase (X-stage).
2. The method of item 1 , wherein the GH8 xylanase is an endo-beta-1 ,4-xylanase.
3. The method of item 1 or 2, wherein the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade.
4. The method of any of items 1 to 3, wherein the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
5. The method of any of items 1 to 4, wherein the GH8 xylanase is derived from Bacillus, such as Bacillus sp. KK-1 , or Bacillus licheniformis; Metagenome from environmental sample; Dyella, such as Dyella sp-62206.
6. The method of any of items 1 to 5, wherein the pulp is wood pulp.
7. The method of any of items 1 to 6, wherein the pulp is a chemical pulp, such as kraft pulp.
8. The method of any of items 1 to 7, which further comprises a step of bleaching and/or alkaline extraction.
9. The method of any of items 1 to 8, comprises a sequence of treatments selected from the group consisting of:
a) X-B;
b) B-X;
c) XB;
wherein,
X is a GH8 xylanase treatment stage,
B is a bleaching stage, preferably a chlorine dioxide bleaching stage, and
XB is a GH8 xylanase treatment together with a bleaching stage.
10. The method of any of items 1 to 9, which further comprises contacting the pulp with one or more additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
1 1. The method of any of items 1-10, wherein an average degree of polymerization of the xylosaccharides in a filtrate from the pulp obtained from the method is 3.5-8, preferably 4-7.
12. The method of any of items 1 to 1 1 , wherein the method results in an improved benefit/harm balance with regard to a positive effect on strength and/or brightness development and/or dewatering of the pulp while minimizing a negative effect on pulp yield, and/or COD of the resulting filtrate/effluent, compared with a method with the GH8 xylanase treatment replaced by a GH10 xylanase treatment or GH1 1 xylanase treatment.
13. A paper pulp prepared by the method of any one of items 1 to 12.
14. A pulp composition, comprising a paper pulp and a GH8 xylanase.
15. The pulp composition of item 14, wherein the GH8 xylanase is an endo-beta-1 ,4- xylanase.
16. The pulp composition of item 14 or 15, wherein the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: the SMDY clade, ALWNW clade, and WFAAAL clade.
17. The pulp composition of any of items 14 to 16, wherein the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
18. The pulp composition of any of items 14 to 17, wherein the paper pulp is wood pulp.
19. The pulp composition of any of items 14 to 18, wherein the paper pulp is a chemical pulp, such as kraft pulp.
20. The pulp composition of any of items 14 to 19, wherein an average degree of polymerization of the xylosaccharides in a filtrate from the pulp is 3.5-8, preferably 4-7.
21. Use of a GH8 xylanase for treating a paper pulp.
22. The use of item 21 , wherein GH8 xylanase improves the brightness and/or strength and/or dewatering of the paper pulp.
The present invention is further described by the following examples which should not be construed as limiting the scope of the invention.
EXAMPLES
Preparation of pulp handsheets
For the measurement of the“ISO brightness” (diffuse blue reflectance factor; ISO 2470- 1), pulp handsheets were prepared according to ISO 3688 and using a Color Touch PC spectrophotometer from Technidyne.
For physical testing, e.g. tensile and burst strength, pulp handsheets were prepared according to TAPPI standard T205. The handsheets were conditioned for at least 24 hours in a controlled humidity (50.0% ± 2.0% RH) and temperature (23.0 ± 1 0°C) atmosphere before being measured in the same room. The physical testing of the handsheets was conducted as described in TAPPI standard T220. The tensile test procedure was based on Tappi standard T using the Instron 5564 tester. The burst test procedure was based on Tappi standard T 403 using a L&W Burst-O-Matic tester.
Aldehyde group measurement in pulp
The amount of aldehyde groups in pulps was measured spectrophotometrically (UV-Vis spectrophotometer HP 8453A, model G1103A) according to the procedure described by Obolenskaya et al., “Determination of aldehyde groups in oxidized pulps”, Laboratory Manipulations in Wood and Cellulose Chemistry, Ecologia, Moscow, 21 1-212, 1991 , which is based on the reaction of 2,3,5-triphenyltetrazolium chloride (TTC) with the aldehyde groups leading to the formation of formazan (red colorant).
Chemical Oxygen Demand (COD) determination
The COD determination in the pulp filtrates was performed using a COD Cell Test from Merck. The reaction cells with the diluted filtrate were put in a thermo reactor TR 620 at 148 °C for 2 hours and then allowed to cool down before measurement in the photometer Spectroquant®
NOVA60 within 60 min after the reaction. The Absorbance of the pulp filtrates was measured with a UV-Vis spectrophotometer HP 8453A, model G1 103A.
Measurement of reducing sugars in filtrates
For the measurement of the reducing sugars (CHO groups) in the pulp filtrates, a microtiter plate method based on p-Hydroxybenzoic acid hydrazide (PHBAH) was utilized as reducing sugars react with hydrazides of benzoic acids in an alkaline medium to yield the bis- benzoylhydrazones of glyoxal and methylglyoxal, both of which had intense yellow color. The rate of reaction was accelerated by the catalytic influence of bismuth ions and the generation of the glyoxal and methylglyoxal derivatives was monitored at 405 nm and was proportional to the amount of reducing sugars concentration as calculated from a standard curve constructed from xylose calibration standards. The pulp filtrates were measured as it was for RS and as well after a secondary enzymatic hydrolysis with a beta-xylosidase (200 pl_ of pulp filtrate at buffered pH 3.5 with 0,002 mg EP/mL at 50°C for 60 min) to convert the small xylosaccharides (XOS) present in the filtrate into xylose and thereby increase the response of the reducing sugar assay. The ratio of the RS value with beta-xylosidase to the RS value without beta-xylosidase was an indication of the average degree of polymerization of the XOS present in the pulp filtrates.
Chemicals used as buffers and substrates were commercial products of at least reagent grade.
Enzymes used in the Examples
EXAMPLE 1 Effect of a xylanase treatment of a market hardwood bleached pulp on pulp and filtrate properties
Bleached northern mixed hardwood kraft pulp in sheet form (dry lap market paper-grade pulp) was teared by hand and soaked in distilled water overnight and then disintegrated in a pulp disintegrator at 10000 rpm. After disintegration, the pulp was filtered and crumbled before being used in the experiments. Typically, 20 g odp (oven-dry pulp; dry matter basis) was treated with a xylanase at 10% consistency, 45°C and pH 4.5 (acetate buffer) for 4 hours using 10 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp suspension was incubated in sealed polyethylene plastic bags immersed in a temperature controlled water bath. After incubation, the pulp was filtered and the filtrate collected. The pulp was then washed and filtered in three consecutive steps with 1 L of warm tap water. Control experiments were run in parallel under the same conditions except for the use of enzyme.
In Table 1 , it is observed that the GH10 and GH1 1 endo-xylanase treatments led to a much higher release of reducing sugars (aldehyde groups, CHO) in the filtrate as compared with the two GH8 endo-xylanases tested. As expected, with the beta-xylosidase treatment of the pulp filtrate, a higher amount of reducing sugars can be measured due to the enzymatic hydrolysis of the XOS. However, a surprisingly higher average degree of polymerization (DP) of the XOS was obtained in the filtrates from the pulps treated with the two GH8 xylanases (DP ca. 6) as compared to the two GH10 (DP = 2.6) and GH1 1 (DP = 3.3) xylanases tested, as estimated by the CHO ratio.
Regarding the amount of reducing end groups (CHO content) in the pulps, the treatment with xylanases increased its amount due to the enzymatic hydrolysis of pulp xylan. However, a surprisingly high amount of CHO groups was attained with the GH8 xylanases (ca. 34 mmol/kg odp) comparable to the amount reached with the GH1 1 xylanase (ca. 35 mmol/kg odp). This was an important finding as the GH8 xylanases led to a very low amount of solubilized xylan in the filtrate as measured by the RS (CHO) measurements in the filtrates. This was further supported by the amount of COD generated by the xylanases (Table 2), as the GH10 xylanase and GH1 1 xylanase generated a much higher amount of COD compared to the GH8 xylanases.
The same tendency was also seen in Absorbance at 280 nm which thus indicated a lower release of aromatic structures associated with xylan by the GH8 xylanases. However, in terms of brightness gain, all tested xylanases could increase the brightness of the pulp to similar extent (Table 3). Therefore, the main advantage with the use of GH8 xylanases was that they produced a more controlled (less severe) hydrolysis of xylan and thereby had a more xylan retaining modification of pulp xylan as compared to the other xylanase families while still improving pulp properties, such as brightness. This had a significant importance as xylan loss needed to be avoided in paper pulp production.
In terms of strength properties, it can be seen in Table 3 that tensile and burst indexes were increased by the xylanases, being highest with the GH 1 1 , followed by the GH8 and then the GH10 xylanase. A positive impact of the GH8 xylanases was thus achieved on strength development while preserving pulp yield and minimizing COD impact as opposed to the GH 10 and GH1 1 xylanases. This again highlights the advantage of using GH8 xylanases since the GH10 and GH 1 1 xylanases may lead to a too severe xylan hydrolysis and thus creating more harm than benefit in the pulp and paper production process.
Table 1 . Evaluation of reducing end groups in the pulps that were treated with xylanases belonging to GH8, GH10 and GH1 1 families and in the resulting pulp filtrates: amount of reducing sugars in the pulp filtrates with and without a secondary hydrolysis with a beta-xylosidase (BX). CHO ratio between the measurements with and without BX treatment is an estimate of the average degree of polymerization of the XOS in the filtrate; amount of reducing end groups (aldehydes) in the treated pulps given as mmol/kg odp.
Table 2. Absorbance and COD of the filtrates from the treated pulps
Table 3. Brightness and strength properties of the treated pulps
EXAMPLE 2 Effect of xylanase treatment in the pre-bleachinq of an unbleached pulp on bleach boosting performance
An unbleached eucalypt kraft pulp was submitted to a sequence of treatments in the following order: xylanase (X-stage), followed by chlorine dioxide bleaching (D-stage) and then an alkaline extraction reinforced with hydrogen peroxide (Ep-stage) with pulp washing in between each stage. Thirty grams of pulp (as oven-dry pulp) were treated at 50°C, pH 6 (phosphate buffer), for 120 min with a dosage of xylanase of 10 mg EP/kg odp. The chlorine dioxide treatment (D-stage) was done using 1 .12 % odp CI0 (100% dosage) or 0.95% odp CI02 (85% dosage), 70°C, initial pH of 3,0 (adjusted with sulfuric acid) for 60 min. The Ep-stage was performed at 75°C, using 1.35 % odp NaOH and 0.20% odp H202 for 60 min. All pulp treatments were run at 10% consistency in sealed polyethylene plastic bags immersed in a temperature controlled water bath.
After each stage the pulp was filtered and washed as described in Example 1. The pulp filtrate was collected to measure the COD.
The use of GH8 and GH10 xylanases in the pre-bleaching of the eucalypt kraft pulp allowed to save ca. 15% CI02 while the GH1 1 xylanase could deliver higher savings (Table 4). However, the higher chlorine dioxide savings were at the cost of a severe loss in pulp yield as indicated by the much higher increase in COD of the filtrates of the GH1 1 treated pulps (Table 5). From a selectivity point of view, the GH8 xylanases revealed a much lower COD impact and thus retained more xylan in the pulp and preserved yield while still enabling ca. 15% CI02 savings.
Table 4. Brightness of the X-D-Ep bleached pulps. D stages with 100% or 85% CI02 as indicated.
Table 5. COD of the filtrates from the treated pulps
EXAMPLE 3 Effect of xylanase treatment in the post-bleaching of a never dried bleached eucalypt kraft pulp
A bleached never dried eucalypt kraft pulp was treated with GH8 and GH1 1 xylanases as a post-bleaching step. 20 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 55°C and pH 6.0 (phosphate buffer) for 2 hours using 1.5, 4.0 and 10 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp was treated and handled as described in Example 1 . Control experiments were run in parallel under the same conditions except for the use of enzyme.
The results shown in Table 6 reveal that all enzyme treatments were able to reach an ISO brightness of ca. 91 % and thus ca. 1.0 brightness point increase. It is once again highlighted the much lower organic load released into the pulp filtrate, as indicated by both the COD and CHO content in the filtrates, attained with the GH8 xylanases at all dosage levels compared to the GH1 1 xylanase. It was again confirmed this xylan preservation effect in the pulp by the GH8 xylanase treatments while still benefiting in terms of a brightness gain to the same level as with the GH1 1 xylanases.
Table 6. Brightness of the treated pulps and COD and reducing sugars in the pulp filtrates
EXAMPLE 4 Effect of xylanase treatment in the post-bleaching of a never dried bleached hardwood kraft pulp
A bleached never dried hardwood kraft pulp was treated with GH8, GH10 and GH1 1 xylanases as a post-bleaching step. 10 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 45°C and pH 6.0 (phosphate buffer) for 3 and 20 hours using 2.0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp was treated and handled as described in Example 1 . Control experiments were run in parallel under the same conditions except for the use of enzyme.
The results shown in Table 7 reveal that all enzyme treatments were able to reach a gain in ISO brightness of at least 0.6-0.8 brightness points with the GH8 xylanases after 3 hours while the GH10 and G1 1 xylanases reached a gain of 0.7 and 1.2, respectively. Similarly, to the previous examples, the brightness gains of the GH8 xylanases were achieved at a lower release of COD into the filtrate and thus preserving more the yield. At an extended time of 20 hours, the GH8 xylanases again confirmed a much lower release of organic load into the filtrate as measured by the COD and reducing sugars. This is important as in full-scale context the pulp can be in contact with the xylanase for a long time in case of stops in the process of pulp production and/or papermaking. The GH8 xylanases show once again a surprisingly higher average degree of polymerization of the released XOS compared to the GH10 and GH1 1 xylanases after a long incubation time of 20h.
Table 7. Brightness of the treated pulps and COD and reducing sugars in the pulp filtrates at two different treatment times
EXAMPLE 5 Effect of xylanase treatment in the post-bleaching of a never dried bleached eucalypt kraft pulp
A bleached never dried hardwood kraft pulp was treated with GH8, GH10 and GH1 1 xylanases as a post-bleaching step. 5 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 65°C and pH 6.0 (phosphate buffer) for 20 hours using 1 .0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp was treated and handled as described in Example 1 . Control experiments were run in parallel under the same conditions except for the use of enzyme.
All tested enzymes increased brightness as seen in Table 8. All GH8 xylanases released less COD than the tested GH10 and GH1 1 xylanases. At the same ISO brightness level, e.g. 89.5±0.1 %, a much lower amount of COD was released by the action of the GH8 xylanases.
Table 8. Brightness of the treated pulps and COD in the resulting pulp filtrates
EXAMPLE 6 Effect of a xylanase treatment using a bleached eucalypt kraft market paper-grade pulp
A bleached eucalypt market kraft paper-grade pulp (dried pulp) was treated with GH8, GH10 and GH1 1 xylanases. 5 g odp (oven-dry pulp; dry matter basis) was treated with xylanases at 10% consistency, 65°C and pH 6.0 (phosphate buffer) for 23 hours using 1.0 mg enzyme protein (EP) / kg odp (oven-dry pulp; dry matter basis). The pulp was treated and handled as described in Example 1. Control experiments were run in parallel under the same conditions except for the use of enzyme.
In Table 9 it can be seen that the GH8 xylanases achieved higher brightness at lower COD release which confirmed once again a more xylan-retaining modification of the pulp in comparison with the GH10 and GH1 1 xylanases that led to higher losses of xylan and thus a higher content of COD in the filtrate.
Table 9. Brightness of the treated pulps and COD in the resulting pulp filtrates
Claims
1. A method for treating a paper pulp, comprising contacting the paper pulp with a GH8 xylanase.
2. The method of claim 1 , wherein the GH8 xylanase is an endo-beta-1 ,4-xylanase.
3. The method of claim 1 or 2, wherein the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade.
4. The method of any of claims 1 to 3, wherein the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
5. The method of any of claims 1 to 4, wherein the pulp is wood pulp.
6. The method of any of claims 1 to 5, comprises a sequence of treatments selected from the group consisting of:
a) X-B;
b) B-X;
c) XB;
wherein,
X is a GH8 xylanase treatment stage,
B is a bleaching stage, preferably a chlorine dioxide bleaching stage, and
XB is a GH8 xylanase treatment together with a bleaching stage.
7. The method of any of claims 1 to 6, which further comprises contacting the pulp with one or more additional enzyme(s) having protease, lipase, xylanase, cutinase, oxidoreductase, cellulase, endoglucanase, amylase, mannanase, steryl esterase, polysaccharide monooxygenase (LPMO) and/or cholesterol esterase activity, preferably a cellulase.
8. The method of any of claims 1 to 7, wherein an average degree of polymerization of the xylosaccharides in a filtrate from the pulp obtained from the method is 3.5-8, preferably 4-7.
9. The method of any of claims 1 to 8, wherein the method results in an improved benefit/harm balance with regard to a positive effect on strength and/or brightness development and/or dewatering of the pulp while minimizing a negative effect on pulp yield, and/or COD of the resulting filtrate/effluent, compared with a method with the GH8 xylanase treatment replaced by a GH10 xylanase treatment or GH1 1 xylanase treatment.
10. A paper pulp prepared by the method of any one of claims 1 to 9.
1 1. A pulp composition, comprising a paper pulp and a GH8 xylanase.
12. The pulp composition of claim 10 or 1 1 , wherein the GH8 xylanase is an endo-beta-1 ,4- xylanase; or wherein the GH8 xylanase is a member of DPSY clade; preferably GH8 xylanase is a member of at least one of the following clades as defined herein: SMDY clade, ALWNW clade, and WFAAAL clade.
13. The pulp composition of any of claims 10 to 12, wherein the GH8 xylanase is selected from the group consisting of:
(a) a polypeptide having at least 60% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; preferably the polypeptide has at least 65%, more preferably at least 70%, more preferably at least 75%, more preferably at least 80%, more preferably at least 85%, even more preferably at least 90%, most preferably at least 95%, and even most preferably at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to a mature polypeptide of any of SEQ ID NO: 1 to SEQ ID NO: 10; and
(b) a polypeptide derived from (a) by substitution, deletion, and/or insertion of one or more (several) amino acids; and
(c) a fragment of the polypeptide of (a), or (b) that has GH8 xylanase activity.
14. Use of a GH8 xylanase for treating a paper pulp.
15. The use of claim 14, wherein GH8 xylanase improves the brightness and/or strength and/or dewatering of the paper pulp.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19188506 | 2019-07-26 | ||
| PCT/EP2020/070900 WO2021018751A1 (en) | 2019-07-26 | 2020-07-24 | Enzymatic treatment of paper pulp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4004279A1 true EP4004279A1 (en) | 2022-06-01 |
Family
ID=67439021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20744037.1A Pending EP4004279A1 (en) | 2019-07-26 | 2020-07-24 | Enzymatic treatment of paper pulp |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4004279A1 (en) |
| CN (1) | CN114402105B (en) |
| BR (1) | BR112022001394A2 (en) |
| WO (1) | WO2021018751A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4230791A1 (en) * | 2022-02-18 | 2023-08-23 | AB Enzymes GmbH | A bleaching process |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK564086A (en) | 1986-11-25 | 1988-06-17 | Novo Industri As | ENZYMATIC DETERGENT ADDITIVE |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| WO1990009446A1 (en) | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
| DK316989D0 (en) | 1989-06-26 | 1989-06-26 | Novo Nordisk As | ENZYMES |
| DE4023458A1 (en) | 1989-08-31 | 1991-03-07 | Kali Chemie Ag | NEW HIGH ALKALINE PROTEASES |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| US5256252A (en) | 1992-07-15 | 1993-10-26 | Nalco Chemical Company | Method for controlling pitch deposits using lipase and cationic polymer |
| GB9216387D0 (en) | 1992-07-31 | 1992-09-16 | Unilever Plc | Enzymatic detergent compositions |
| DK144192D0 (en) | 1992-12-01 | 1992-12-01 | Novo Nordisk As | ENZYMER ACTIVATION |
| EP0802981A1 (en) | 1992-12-23 | 1997-10-29 | Unilever N.V. | Modified cutinases, dna, vector and host |
| US5681862A (en) | 1993-03-05 | 1997-10-28 | Buckman Laboratories International, Inc. | Ionene polymers as microbicides |
| ES2147579T3 (en) | 1993-06-16 | 2000-09-16 | Call Hans Peter | BLEACHING SYSTEM OF MULTIPLE COMPONENTS. |
| DK77393D0 (en) | 1993-06-29 | 1993-06-29 | Novo Nordisk As | ENZYMER ACTIVATION |
| US5480801A (en) | 1993-09-17 | 1996-01-02 | Novo Nordisk A/S | Purified PH neutral Rhizoctonia laccases and nucleic acids encoding same |
| WO1995011964A1 (en) | 1993-10-26 | 1995-05-04 | Novo Nordisk A/S | Myxococcaceae peroxidase |
| DE4343591A1 (en) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Process for the evolutionary design and synthesis of functional polymers based on shape elements and shape codes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| PT763115E (en) | 1994-06-03 | 2001-03-30 | Novo Nordisk Biotech Inc | SCYTALIDIUM PURIFIED LACASES AND NUCLEIC ACIDS THAT ENCODES THEM |
| FI964808A0 (en) | 1994-06-03 | 1996-12-02 | Novo Nordisk Biotech Inc | Purified Myceliophthora lacquers and nucleic acids encoding them |
| CN1329514C (en) | 1994-06-24 | 2007-08-01 | 诺沃奇梅兹有限公司 | Purified polyporus laccase and nucleic acid encoding the enzyme |
| US5575993A (en) | 1994-08-31 | 1996-11-19 | Buckman Laboratories International, Inc. | Ionene polymers containing biologically-active anions |
| EP0781328B1 (en) | 1994-09-27 | 2002-12-04 | Novozymes A/S | Enhancers such as acetosyringone |
| US5827719A (en) | 1994-10-26 | 1998-10-27 | Novo Nordisk A/S | Enzyme with lipolytic activity |
| US5770012A (en) * | 1994-11-18 | 1998-06-23 | P. H. Glatfelter Co. | Process for treating paper machine stock containing bleached hardwood pulp with an enzyme mixture to reduce vessel element picking |
| US6008029A (en) | 1995-08-25 | 1999-12-28 | Novo Nordisk Biotech Inc. | Purified coprinus laccases and nucleic acids encoding the same |
| US6057438A (en) * | 1996-10-11 | 2000-05-02 | Eastman Chemical Company | Process for the co-production of dissolving-grade pulp and xylan |
| AU8020398A (en) | 1997-06-10 | 1998-12-30 | Unilever Plc | Method for enhancing the activity of an enzyme, bleach composition, detergent composition and process for inhibiting dye transfer |
| WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
| MXPA02011911A (en) | 2000-06-02 | 2003-05-27 | Novozymes As | Cutinase variants. |
| US6372464B1 (en) | 2000-06-19 | 2002-04-16 | Novozymes Biotech, Inc. | Polypeptides having peroxidase activity and nucleic acids encoding same |
| CA2432788C (en) * | 2000-12-22 | 2008-10-07 | Iogen Bio-Products Corporation | Alkaline extraction stages comprising xylanase |
| CA2477847A1 (en) * | 2002-03-06 | 2003-09-12 | Iogen Bio-Products Corporation | Xylanase treatment of chemical pulp |
| US20040112555A1 (en) * | 2002-12-03 | 2004-06-17 | Jeffrey Tolan | Bleaching stage using xylanase with hydrogen peroxide, peracids, or a combination thereof |
| CN103667215A (en) | 2004-02-06 | 2014-03-26 | 诺维信股份有限公司 | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| CN102325879A (en) | 2008-12-19 | 2012-01-18 | 诺维信股份有限公司 | Method of increasing hydrolysis of cellulosic material in the presence of cellobiose dehydrogenase |
| AU2010329917B2 (en) * | 2009-12-09 | 2014-12-04 | Novozymes A/S | Methods of producing GH8 xylanase variants |
| ES2908691T3 (en) * | 2011-10-27 | 2022-05-03 | Buckman Laboratories Int Inc | Method and composition for the enzymatic treatment of fiber for the manufacture of paper, and paper products made from it |
| WO2014066141A2 (en) | 2012-10-24 | 2014-05-01 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| EP3030710B1 (en) * | 2013-08-09 | 2017-10-11 | Novozymes A/S | Reducing content of hexenuronic acids in cellulosic pulp |
| WO2016079045A1 (en) * | 2014-11-17 | 2016-05-26 | Novozymes A/S | Enzymatic process combined with hot caustic extraction for the removal of hemicelluloses from paper-grade pulp |
| US20190257031A1 (en) * | 2015-10-23 | 2019-08-22 | Novozymes A/S | Use of Cellulase to improve Viscosity Control of Dissolving Pulp |
| CA3083854A1 (en) * | 2017-12-22 | 2019-06-27 | Novozymes A/S | Wheat milling process and gh8 xylanases |
-
2020
- 2020-07-24 BR BR112022001394A patent/BR112022001394A2/en unknown
- 2020-07-24 CN CN202080049482.3A patent/CN114402105B/en active Active
- 2020-07-24 EP EP20744037.1A patent/EP4004279A1/en active Pending
- 2020-07-24 WO PCT/EP2020/070900 patent/WO2021018751A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021018751A1 (en) | 2021-02-04 |
| CN114402105B (en) | 2024-01-30 |
| BR112022001394A2 (en) | 2022-03-22 |
| CN114402105A (en) | 2022-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kulkarni et al. | Application of xylanase from alkaliphilic thermophilic Bacillus sp. NCIM 59 in biobleaching of bagasse pulp | |
| AU2002336917B2 (en) | Oxidizing enzymes in the manufacture of paper materials | |
| US10570562B2 (en) | Methods for reducing content of hexenuronic acids in cellulosic pulp | |
| CN1997791A (en) | Method for mechanical pulp production | |
| AU2002336917A1 (en) | Oxidizing enzymes in the manufacture of paper materials | |
| US20030124710A1 (en) | Oxidizing enzymes in the manufacture of paper materials | |
| Garg et al. | Biobleaching effect of Streptomyces thermoviolaceus xylanase preparations on birchwood kraft pulp | |
| EP2929086B1 (en) | Method for treating a pulp with an enzyme | |
| EP2588665B1 (en) | Bleaching of pulp | |
| WO2016073610A1 (en) | Xylanase based bleach boosting | |
| US20160237618A1 (en) | Enzymatic bleaching of paper pulp | |
| WO2021018751A1 (en) | Enzymatic treatment of paper pulp | |
| EP2753749B1 (en) | Improving properties of paper materials | |
| Bajpai | Biobleaching | |
| CA2241517C (en) | Production of sanitary paper | |
| Bissoon | Evaluation of the Bleach-enhancing Effects of Xylanases on Bagasse-soda Pulp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220228 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) |